Pathologic Complete Response and Individual Patient Prognosis After Neoadjuvant Chemotherapy Plus Anti–Human Epidermal Growth Factor Receptor 2 Therapy of Human Epidermal Growth Factor Receptor ...
Luca Antonelli, MD; Davide Ardizzone, MD; Isamu Tachibana, MD; Nabil Adra, MD; Clint Cary, MD; Lee Hugar, MD; Wade J. Sexton, MD; Aditya Bagrodia, MD; Michal Mego, MD ...
On the basis of National Comprehensive Cancer Network guidelines, clinical stage (CS) II seminoma is treated with radiotherapy or chemotherapy. Primary retroperitoneal lymph node dissection (RPLND) ...
With the goals of informing surgical management, improving long-term outcomes and lowering death rates of patients with testicular cancer, a study has found that the conventional, versatile open ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results